In the hypoxic tumor microenvironment, the transcriptional regulation of HIF1A mediates the upregulation of PLOD2, which can activate EGFR phosphorylation, thereby activating the downstream AKT-mTOR pathway and ultimately promoting ccRCC tumor progression. The gene discussed is EGFR; the disease is nonpapillary renal cell carcinoma.